Skip to content

Cannabis research published in 2023

Page 8 of 9: studies 141 to 160 of 166, newest first. Back to the cannabis overview

Studies

Impaired Ghrelin Signaling Does Not Lead to Alterations of Anxiety-like Behaviors in Adult Mice Chronically Exposed to THC during Adolescence

Biomedicines January 6, 2023 Matija Šestan-Peša, Marya Shanabrough, Tamás L. Horváth et al. 4 citations

As marijuana use during adolescence has been increasing, the need to understand the effects of its long-term use becomes crucial. Previous research suggested that marijuana consumption during adolescence increases the risk of developing mental illnesses, such as schizophrenia, depression, and anxiety. Ghrelin is a peptide produced primarily in the gut and is important for feeding behavior....

Cannabidiol and brain function: current knowledge and future perspectives.

Frontiers in Pharmacology 2023 Moniek Schouten, Sebastiaan Dalle, Dante Mantini et al.

Cannabidiol (CBD) is a naturally occurring non-psychoactive cannabinoid found in Cannabis sativa, commonly known as cannabis or hemp. Although currently available CBD products do not meet the safety standards of most food safety authorities to be approved as a dietary supplement or food additive, CBD has been gaining widespread attention in recent years due to its various potential health...

Prospective, longitudinal study to isolate the impacts of marijuana use on neurocognitive functioning in adolescents.

Frontiers in Psychiatry 2023 Wen Ren, Diana H Fishbein

Policies to legalize possession and use of marijuana have been increasingly supported across the United States. Although there are restrictions on use in minors, many substance abuse scientists anticipate that these policy changes may alter use patterns among adolescents due to its wider availability and a softening of beliefs about its potentially harmful consequences. Despite the possibility...

DOI: 10.3389/fpsyt.2023.1048791 (opens in new tab) Full text (opens in new tab) Adolescence Emotion recognition Legalization Longitudinal +3

Chronic exposure to inhaled vaporized cannabis high in Δ9-THC alters brain structure in adult female mice.

Frontiers in Neuroscience 2023 Autumn Taylor, Amanda Nweke, Veniesha Vincent et al.

The medical and recreational use of cannabis has increased in the United States. Its chronic use can have detrimental effects on the neurobiology of the brain-effects that are age-dependent. This was an exploratory study looking at the effects of chronically inhaled vaporized cannabis on brain structure in adult female mice. Adult mice were exposed daily to vaporized cannabis (10.3% THC and...

DOI: 10.3389/fnins.2023.1139309 (opens in new tab) Full text (opens in new tab) Diffusion weighted imaging Dopaminergic system Limbic cortex Prefrontal cortex pfc +1

Combining noninvasive brain stimulation with behavioral pharmacology methods to study mechanisms of substance use disorder.

Frontiers in Neuroscience 2023 Michael J Wesley, Joshua A Lile

Psychotropic drugs and transcranial magnetic stimulation (TMS) are effective for treating certain psychiatric conditions. Drugs and TMS have also been used as tools to explore the relationship between brain function and behavior in humans. Combining centrally acting drugs and TMS has proven useful for characterizing the neural basis of movement. This combined intervention approach also holds...

Δ9-Tetrahydrocannabinol does not upregulate an aversive dopamine receptor mechanism in adolescent brain unlike in adults.

Current Research in Neurobiology 2023 Marie-Eve Di Raddo, Marija Milenkovic, Meenalochani Sivasubramanian et al.

Earlier age of cannabis usage poses higher risk of Cannabis Use Disorder and adverse consequences, such as addiction, anxiety, dysphoria, psychosis, largely attributed to its principal psychoactive component, Δ9-tetrahydrocannabinol (THC) and altered dopaminergic function. As dopamine D1-D2 receptor heteromer activation causes anxiety and anhedonia, this signaling complex was postulated to...

Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial.

Frontiers in Public Health 2023 Sarah Hartley, Nicolas Simon, Bibiana Cardozo et al.

To study the effect of inhaled cannabis on self-assessed predicted driving ability and its relation to reaction times and driving ability on a driving simulator. 30 healthy male volunteers aged 18-34: 15 chronic (1-2 joints /day) and 15 occasional (1-2 joints/week) consumers. Self-assessed driving confidence (visual analog scale), vigilance (Karolinska), reaction time (mean reciprocal reaction...

Impact of early-life lead exposure on adult delta-9-tetrahydrocannabinol sensitivity in male and female C57BL6/J mice.

Neurotoxicology and Teratology 2023 Daniel Garcy, Stephen L Boehm

Environmental exposure to lead (Pb) and cannabis use are two of the largest public health issues facing modern society in the United States and around the world. Exposure to Pb in early life has been unequivocally shown to have negative impacts on development, and recent research is mounting showing that it may also predispose individuals for risk of developing substance use disorders (SUD). At...

DOI: 10.1016/j.ntt.2023.107290 (opens in new tab) Full text (opens in new tab) Environmental toxins Leadpb Δ-9-tetrahydrocannabinolthc sensitivity

Cannabis: 12,000 years of experiences and prejudices

Brazilian Journal Of Pain 2023 Pedro Antonio Pierro Neto, Luiz Marcelo Chiarotto Pierro, Sergio Tadeu Fernandes 8 citations

BACKGROUND AND OBJECTIVES: Cannabis Sativa has been part of human evolution and has been used by different populations for different purposes. By reviewing the history and main advances in cannabinoid medicine, the aim of this study was to identify the major discoveries in recent years, which have prompted the publication of articles. CONTENTS: The following topics were searched: “history of...

Vaporized Delta-9-tetrahydrocannabinol Inhalation in Female Sprague Dawley Rats: A Pharmacokinetic and Behavioral Assessment.

Current Pharmaceutical Design 2023 Samantha L Penman, Erin C. Berthold, Abrianna Mihalkovic et al.

Delta-9-tetrahydrocannabinol (THC) is the main psychoactive component of cannabis. Historically, rodent studies examining the effects of THC have used intraperitoneal injection as the route of administration, heavily focusing on male subjects. However, human cannabis use is often through inhalation rather than injection. We sought to characterize the pharmacokinetic and phenotypic profile of...

DOI: 10.2174/1381612829666230419093809 (opens in new tab) Full text (opens in new tab) Cannabis Delta-9-Tetrahydrocannabinol THC Liquid-chromatography/mass-spectrometry Locomotor activity. +2

Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder.

Frontiers in Neuroscience 2023 Jenika Staben, Megan Koch, Keelee Reid et al.

Cannabidiol (CBD) is a non-intoxicating phytocannabinoid with increasing popularity due to its purported therapeutic efficacy for numerous off-label conditions including anxiety and autism spectrum disorder (ASD). Those with ASD are commonly deficient in endogenous cannabinoid signaling and GABAergic tone. CBD has a complex pharmacodynamic profile that includes enhancing GABA and...

The Naturalistic Cannabis Administration Protocol (NCAP): A Proof-of-Concept Study.

Journal of Psychoactive Drugs 2023 Michelle St Pierre, Sarah Daniels, Tatiana A Sanchez et al.

Lab-based studies examining the effects of cannabis administration on human behavior compromise ecological validity due to the influence of set and setting. Contextual factors of clinical settings have long been recognized as producing measurable changes in physiology, emotionality, and cognition. Among people who use drugs, these settings may be associated with higher levels of perceived...

DOI: 10.1080/02791072.2022.2125466 (opens in new tab) Full text (opens in new tab) Methodology Acute cannabis intoxication Cannabis research Experimental design

Sleep as a Mediator Between Cannabis Use and Psychosis Vulnerability: A Longitudinal Cohort Study

Schizophrenia Bulletin Open 2023 Julien Ouellet, Sean Spinney, Roxane Assaf et al.

Abstract Objectives Increasing evidence implicates cannabis consumption as a key risk factor in the development of psychosis, but the mechanisms underpinning this relationship remain understudied. This study proposes to determine whether sleep disruption acts as a mediator of the cannabis-to-psychosis relationship. Study Design This longitudinal study assessed measures of cannabis use...

Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example

Epidemiology and Psychiatric Sciences 2023 Gianfranco Di Gennaro, Marco Colizzi

Abstract The psychoactive properties of cannabis have been known forever. Since 1987, several prospective studies have suggested an increased risk of psychosis among cannabis users, with alternative explanations failing to account for such an effect. A cause–effect relationship has thus been implied. Further evidence has indicated that there is a dose–response relationship, and high-potency...

A Latent Variable Analysis of Psychomotor and Neurocognitive Performance After Acute Cannabis Smoking

Cannabis 2023 Shelby Smith, Julia Wrobel, Ashley Brooks-Russell et al.

Objective. This paper evaluated a novel, tablet-based neurocognitive and psychomotor test battery for detecting impairment from acute cannabis smoking using advanced quantitative methods. The study was conducted in a state with legal, recreational cannabis use and included participants who use cannabis occasionally or daily, and a no use comparison group. Methods. Participants completed a...

Single cannabidiol administration affects anxiety-, obsessive compulsive-, object memory-, and attention-like behaviors in mice in a sex and concentration dependent manner.

Pharmacology, Biochemistry, and Behavior January 2023 Carley Marie Huffstetler, Brigitte Cochran, Camilla Ann May et al.

The behavioral effects of cannabidiol (CBD) are understudied, but are important, given its therapeutic potential and widespread use as a natural supplement. The objective of this study was to test whether a single injection of CBD affected anxiety-like or attention-like behavior, or memory in wildtype mice or mice with reported trait anxiety due to a targeted gene-deletion in a...

Cannabis: Drug of Abuse and Therapeutic Agent, Two Sides of the Same Coin.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 2023 Ana Canseco-Alba, Gabriela Rodríguez-Manzo

The consumption of Cannabis sativa plant, known as marijuana in the Western world, for different purposes (therapeutic, intoxicating, and spiritual) due to its psychoactive effects, can be traced back to ancient times. Cannabis is the most used illicit drug worldwide; however, its legal status is changing rapidly. Cannabis regulation will allow a better understanding of its effects as a misused...

DOI: 10.24875/ric.23000112 (opens in new tab) Full text (opens in new tab) Marijuana Cannabinoids Cannabis sativa Cannabis-based treatments +2

Relationship Between Cannabis Use and Immediate, Delayed, and Working Memory Performance Among Older Adults

Cannabis 2023 Madison Maynard, Daniel Paulson, Michael Dunn et al.

Cannabis is increasingly accessible and use is increasing rapidly among older adults as laws change and cannabis becomes more frequently prescribed in healthcare settings. Past research identified cognitive effects of cannabis use among adolescents and young adults that can persist for several weeks after intoxication, though little is known about how these effects generalize to older adults....

Medical Cannabis sativa (Marijuana or drug type): Psychoactive molecule, Δ9-Tetrahydrocannabinol (Δ9-THC)

International Journal of Research and Innovation in Applied Science 2023 Ravindra B. Malabadi, Kiran P. Kolkar, Raju K. Chalannavar et al. 4 citations

This review paper highlights about Medical Cannabis sativa (Marijuana or drug type) containing psychoactive molecule, Δ9-Tetrahydrocannabinol (Δ9-THC) as a part of educational awareness programme in India. Cannabis sativa and Cannabis indica were originally a native of India growing as a wild notorious noxious weed in the Indian Himalayan region. Marijuana (Charas, Ganja and Bhang in India) is...

Role of cyclin-dependent kinase 5 in psychosis and the modulatory effects of cannabinoids.

Neurobiology of Disease 2023 Marta Barrera-Conde, Emma Veza-Estévez, Maria Gomis-Gonzalez et al.

Cyclin-dependent kinase 5 (CDK5) is a serine/threonine kinase that has emerged as a key regulator of neurotransmission in complex cognitive processes. Its expression is altered in treated schizophrenia patients, and cannabinoids modulate CDK5 levels in the brain of rodents. However, the role of this kinase, and its interaction with cannabis use in first-episode psychosis (FEP) patients is still...

DOI: 10.1016/j.nbd.2022.105942 (opens in new tab) Full text (opens in new tab) Cannabis First-episode psychosis Human olfactory neuroepithelium Mice models +1